Welcome to LookChem.com Sign In|Join Free

CAS

  • or

98759-73-0

Post Buying Request

98759-73-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

98759-73-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 98759-73-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,7,5 and 9 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 98759-73:
(7*9)+(6*8)+(5*7)+(4*5)+(3*9)+(2*7)+(1*3)=210
210 % 10 = 0
So 98759-73-0 is a valid CAS Registry Number.

98759-73-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name dioxosilane,hydrate

1.2 Other means of identification

Product number -
Other names Dioxosilane Hydrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:98759-73-0 SDS

98759-73-0Upstream product

98759-73-0Downstream Products

98759-73-0Relevant articles and documents

THERAPEUTIC COMPOSITIONS CONTAINING GLUTATHIONE ANALOGS

-

, (2008/06/13)

Pharmaceutical compositions and methods of using them. Lipid formulations of a glutathione analog and methods of manufacturing them. Their use to stimulate hematopoiesis, protect hematopoietic cells from damage caused by radiation or chemotherapy, or potentiate the stimulatory action of one or a combination of cytokines on colony formation by hematopoietic progenitor cells, protect a subject from a destructive effect of a chemotherapeutic agent or irradiation, or to potentiate the effect of a chemotherapeutic agent.

5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same

-

, (2008/06/13)

The present invention provides novel PGI2derivatives and an anti Helicobacter agent, a platelet function potentiating agent or a cervical ripening agent containing any of the derivatives.

Modulators of LXR

-

, (2008/06/13)

Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of nuclear receptors, including liver X receptor (LXR) and orphan nuclear receptors. In certain embodiments, the compounds are N-substituted pyridones.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 98759-73-0